Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007

UPPSALA, Sweden and WILMINGTON, Massachusetts, August 31 /PRNewswire/ --

- EBAC-Accredited Workshop Set for Sept. 3

Nico Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present
the benefits of measuring coronary pressure, or Fractional Flow Reserve
(FFR), in improving the outcomes of multivessel PCI in a workshop at the
European Society of Cardiology (ESC) Congress 2007 in Vienna. The
EBAC-accredited workshop, which is sponsored by Radi Medical Systems, will
take place at 12:45 p.m. CEST on Monday, Sept. 3, in the Copenhagen Room in
Zone 1 of the Messe Wien Conference Center.

Dr. Pijls, of the department of cardiology at Catharina Hospital in
Eindhoven, the Netherlands, will cover "Assessment Of Ischaemia In The
Cathlab: The Best And Easiest Way To Go." Dr. de Bruyne, with the
Cardiovascular Center Aalst in Aalst, Belgium, will explore the "Diagnosis
And Treatment Of Multivessel Disease: All In One." Both physicians were
investigators in the DEFER study, which evaluated the appropriateness of
stenting a coronary stenosis (abnormal narrowing) that appears to be
angiographically significant but is not restricting blood flow enough to
cause symptoms. Five-year results were published in the May 29 issue of the
Journal of the American College of Cardiology.

About FFR

FFR expresses maximum achievable blood flow in a coronary artery with
abnormal stenosis as a fraction of normal maximum blood flow in the absence
of a stenosis. It is calculated using an interventional guidewire with a
specially designed sensor built into it. Using the well established value of
0.75, FFR is 100% specific in identifying which lesions are actually causing
flow restriction and can be treated. FFR also documents the exact percentage
of the reduction in flow associated with each lesion.

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical
devices designed to improve patient care. The company's pioneering work in
the field of interventional cardiology has resulted in market-leading
intravascular sensors and hemostasis management and radiology devices. Radi
works closely with medical practitioners to develop solutions that address
clinical needs, as well as provide clinical education support. Founded in
1988, Radi employs more than 350 people globally and has representation in
more than 40 countries. The company is based in Uppsala, Sweden, and
maintains a U.S. headquarters in Wilmington, Mass. For more information,
visit www.radi.se.

Media Contacts:

    David Schull or Benjamin Carmichael
    Russo Partners LLC
    +1-212-845-4271
    david.schull@russopartnersllc.com
    benjamin.carmichael@russopartnersllc.com

    Jim Archetto
    Radi Medical Systems Inc.
    +1-877-337-7234 x812
    jim.archetto@radi.se



Web site: http://www.radi.se